Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, August 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Enterovirus Monoclonal Antibodies
Saturday, March 08, 2014
New pan-reactive antibody is positive for all 27 Enteroviruses.

Abcam Introduces Alexa Fluor® 680/790 Secondary Antibodies
Tuesday, March 04, 2014
New range offers high performance antibodies for more efficient western blotting.

Bio-Rad Introduces Bio-Plex Manager™ MP Software Upgrade for All MAGPIX Multiplex Readers
Friday, February 14, 2014
Bio-Rad Laboratories, Inc. announce the release of its Bio-Plex Manager MP Software Upgrade, which runs on all Luminex-based MAGPIX readers.

Merck Millipore Launches guava easyCyte™ 12 Flow Cytometer
Thursday, February 06, 2014
Provides 12 simultaneous detection parameters, including 10 fluorescent colors.

Hamilton Robotics Launches Microlab® Immunostain NIMBUS® Workstation
Tuesday, January 28, 2014
The Immunostain NIMBUS provides hands-free fluorescent staining at an affordable price.

Aptamer Kits for Cell Isolation & Flow Cytometry
Monday, January 27, 2014
Deliver unmatched convenience, increased consistency and reliability.

PerkinElmer Introduces Novel Research Tools at SLAS 2014
Monday, January 27, 2014
PerkinElmer Inc. introduced several novel products at SLAS2014, including the Opera® Phenix™ high content screening system, JANUS® chemagic nucleic acid workstation.

Techne’s New Range of Dri-block® Heaters Given a New Look and Increased Functionality
Thursday, January 16, 2014
Enhanced levels of choice, flexibility and specification are offered.

Compugen to Significantly Expand Immuno-Oncology Activities During 2014
Wednesday, January 08, 2014
R&D expenditures for 2014 anticipated to increase by more than 60%.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 346
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv